INS and obesity due to melanocortin 4 receptor deficiency: The results suggest that gossypol may have therapeutical potential for modulating inflammation, glucose transport and insulin signaling-related diseases such as arthritis, diabetes and obesity, although more research is needed to confirm the findings at the mRNA level with protein and metabolite levels as well as using animal models.